This was a 12-week, single-arm, open-label trial
performed at a single site in the United States. Subjects
were required to be female, within the ages of 40 and 60
with Fitzpatrick classification I to IV with early to advanced
photodamaged facial skin (Modified Glogau classification
II–III). All subjects were required to provide written,
informed consent.